topicMethylsulfonylmethane Joint Pain Meta-Analysis
claimEffective management of KOA is therefore crucial not only for improving the patient’s quality of life but also for reducing the associated economic burden.
evidence level1
citationSumsuzzman Dewan Md. (2024)
sourceComparative Efficacy of Glucosamine-Based Combination Therapies in Alleviating Knee Osteoarthritis Pain: A Systematic Review and Network Meta-Analysis
topicMethylsulfonylmethane Joint Pain Meta-Analysis
claim5 6 7 8 9 10 11 12 13 13 Managing KOA pain mainly relies on NSAIDs, but their prolonged use raises the risk of gastrointestinal and cardiovascular adverse events [].
evidence level1
citationSumsuzzman Dewan Md. (2024)
sourceComparative Efficacy of Glucosamine-Based Combination Therapies in Alleviating Knee Osteoarthritis Pain: A Systematic Review and Network Meta-Analysis
topicMethylsulfonylmethane Joint Pain Meta-Analysis
claimHowever, the American College of Rheumatology conditionally does not recommend the use of glucosamine for treating KOA [].
evidence level1
citationSumsuzzman Dewan Md. (2024)
sourceComparative Efficacy of Glucosamine-Based Combination Therapies in Alleviating Knee Osteoarthritis Pain: A Systematic Review and Network Meta-Analysis
topicMethylsulfonylmethane Joint Pain Meta-Analysis
claim1 2 3 4 Osteoarthritis (OA) remains a major global health issue, with its prevalence rising with age and varying across different geographic regions and anatomic sites [].
evidence level1
citationSumsuzzman Dewan Md. (2024)
sourceComparative Efficacy of Glucosamine-Based Combination Therapies in Alleviating Knee Osteoarthritis Pain: A Systematic Review and Network Meta-Analysis
topicMethylsulfonylmethane Joint Pain Meta-Analysis
claimTemporomandibular disorders (TMDs) encompass a spectrum of musculoskeletal and joint conditions of the masticatory system that frequently lead to chronic pain, limited function, and reduced quality of life.
evidence level3
citationGazali M (2026)
sourceDiagnosis-based pathways for conservative and minimally invasive management of temporomandibular disorders: a scoping review.
topicMethylsulfonylmethane Joint Pain Meta-Analysis
claimAlthough conservative and minimally invasive approaches are recommended as first-line therapies, their comparative efficacy remains unclear.This scoping review mapped evidence from randomized controlled trials (RCTs) published between 2015 and 2025 to identify diagnosis-based effective management pathways for TMDs.
evidence level3
citationGazali M (2026)
sourceDiagnosis-based pathways for conservative and minimally invasive management of temporomandibular disorders: a scoping review.
topicMethylsulfonylmethane Joint Pain Meta-Analysis
claimOverall, the evidence from the past decade supports a diagnosis-driven, stepwise model that emphasizes conservative multimodal care as the cornerstone of TMD management.
evidence level3
citationGazali M (2026)
sourceDiagnosis-based pathways for conservative and minimally invasive management of temporomandibular disorders: a scoping review.